OBJECTIVE: To compare the clinical characteristics and outcomes of patients with community-acquired and hospital-acquired sepsis. METHODS: This is a retrospective cohort study that included all patients with a diagnosis of sepsis detected between January 2010 and December 2015 at a private hospital in southern Brazil. Outcomes (mortality, intensive care unit and hospital lengths of stay) were measured by analyzing electronic records. RESULTS: There were 543 hospitalized patients with a diagnosis of sepsis, with a frequency of 90.5 (85 to 105) cases/year. Of these, 319 (58%) cases were classified as hospital-acquired sepsis. This group exhibited more severe disease and had a larger number of organ dysfunctions, with higher hospital [8 (8 - 10) versus 23 (20 - 27) days; p < 0.001] and intensive care unit [5 (4 - 7) versus 8.5 (7 - 10); p < 0.001] lengths of stay and higher in-hospital mortality (30.7% versus 15.6%; p < 0.001) than those with community-acquired sepsis. After adjusting for age, APACHE II scores, and hemodynamic and respiratory dysfunction, hospital-acquired sepsis remained associated with increased mortality (OR 1.96; 95%CI 1.15 - 3.32, p = 0.013). CONCLUSION: The present results contribute to the definition of the epidemiological profile of sepsis in the sample studied, in which hospital-acquired sepsis was more severe and was associated with higher mortality.
OBJECTIVE: To compare the clinical characteristics and outcomes of patients with community-acquired and hospital-acquired sepsis. METHODS: This is a retrospective cohort study that included all patients with a diagnosis of sepsis detected between January 2010 and December 2015 at a private hospital in southern Brazil. Outcomes (mortality, intensive care unit and hospital lengths of stay) were measured by analyzing electronic records. RESULTS: There were 543 hospitalized patients with a diagnosis of sepsis, with a frequency of 90.5 (85 to 105) cases/year. Of these, 319 (58%) cases were classified as hospital-acquired sepsis. This group exhibited more severe disease and had a larger number of organ dysfunctions, with higher hospital [8 (8 - 10) versus 23 (20 - 27) days; p < 0.001] and intensive care unit [5 (4 - 7) versus 8.5 (7 - 10); p < 0.001] lengths of stay and higher in-hospital mortality (30.7% versus 15.6%; p < 0.001) than those with community-acquired sepsis. After adjusting for age, APACHE II scores, and hemodynamic and respiratory dysfunction, hospital-acquired sepsis remained associated with increased mortality (OR 1.96; 95%CI 1.15 - 3.32, p = 0.013). CONCLUSION: The present results contribute to the definition of the epidemiological profile of sepsis in the sample studied, in which hospital-acquired sepsis was more severe and was associated with higher mortality.
Authors: E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich Journal: N Engl J Med Date: 2001-11-08 Impact factor: 91.245
Authors: Glauco A Westphal; Álvaro Koenig; Milton Caldeira Filho; Janaína Feijó; Louise Trindade de Oliveira; Fernanda Nunes; Kênia Fujiwara; Sheila Fonseca Martins; Anderson R Roman Gonçalves Journal: J Crit Care Date: 2010-10-30 Impact factor: 3.425
Authors: Corinne Alberti; Christian Brun-Buisson; Hilmar Burchardi; Claudio Martin; Sergey Goodman; Antonio Artigas; Alberto Sicignano; Mark Palazzo; Rui Moreno; Ronan Boulmé; Eric Lepage; Roger Le Gall Journal: Intensive Care Med Date: 2001-12-04 Impact factor: 17.440
Authors: R Beale; K Reinhart; F M Brunkhorst; G Dobb; M Levy; G Martin; C Martin; G Ramsey; E Silva; B Vallet; J-L Vincent; J M Janes; S Sarwat; M D Williams Journal: Infection Date: 2009-04-28 Impact factor: 3.553
Authors: Ana M C Sogayar; Flavia R Machado; Alvaro Rea-Neto; Amselmo Dornas; Cintia M C Grion; Suzana M A Lobo; Bernardo R Tura; Carla L O Silva; Ruy G R Cal; Idal Beer; Vilto Michels; Jorge Safi; Marcia Kayath; Eliezer Silva Journal: Pharmacoeconomics Date: 2008 Impact factor: 4.981
Authors: Ricard Ferrer; Antonio Artigas; Mitchell M Levy; Jesús Blanco; Gumersindo González-Díaz; José Garnacho-Montero; Jordi Ibáñez; Eduardo Palencia; Manuel Quintana; María Victoria de la Torre-Prados Journal: JAMA Date: 2008-05-21 Impact factor: 56.272
Authors: Sandra Christina Pereira Lima Shiramizo; Alexandre R Marra; Marcelino S Durão; Ângela T Paes; Michael B Edmond; Oscar Fernando Pavão dos Santos Journal: PLoS One Date: 2011-11-03 Impact factor: 3.240